Your browser doesn't support javascript.
loading
Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors.
Huang, Weize; Stader, Felix; Chan, Phyllis; Shemesh, Colby S; Chen, Yuan; Gill, Katherine L; Jones, Hannah M; Li, Linzhong; Rossato, Gianluca; Wu, Benjamin; Jin, Jin Y; Chanu, Pascal.
Afiliación
  • Huang W; Genentech Inc, South San Francisco, CA, United States.
  • Stader F; Certara UK Limited, Sheffield, United Kingdom.
  • Chan P; Genentech Inc, South San Francisco, CA, United States.
  • Shemesh CS; Genentech Inc, South San Francisco, CA, United States.
  • Chen Y; Genentech Inc, South San Francisco, CA, United States.
  • Gill KL; Certara UK Limited, Sheffield, United Kingdom.
  • Jones HM; Certara UK Limited, Sheffield, United Kingdom.
  • Li L; Certara UK Limited, Sheffield, United Kingdom.
  • Rossato G; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Wu B; Genentech Inc, South San Francisco, CA, United States.
  • Jin JY; Genentech Inc, South San Francisco, CA, United States.
  • Chanu P; Genentech Inc, South San Francisco, CA, United States.
Front Pharmacol ; 13: 974423, 2022.
Article en En | MEDLINE | ID: mdl-36225583
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos